CH d'Angers/Service des Maladies du sang

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Acute myeloid leukaemia
• Myelodysplastic syndromes

Running trials

• Active, not recruiting

  IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome

  NCT03744390· Phase 2· Groupe Francophone des Myelodysplasies· Source